Recap: Immunovant Q3 Earnings

Immunovant IMVT reported its Q3 earnings results on Monday, February 12, 2024 at 07:00 AM.

Here's what investors need to know about the announcement.

Earnings

Immunovant beat estimated earnings by 16.28%, reporting an EPS of $-0.36 versus an estimate of $-0.43.

Revenue was down $0 from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.03 which was followed by a 4.22% increase in the share price the next day.

To track all earnings releases for Immunovant visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.